Back to Journals » Clinical Ophthalmology » Volume 6

Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity

Authors Shah NV, Houston SK, Markoe AM, Feuer W, Murray TG

Received 12 June 2012

Accepted for publication 6 July 2012

Published 29 October 2012 Volume 2012:6 Pages 1739—1748


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Nisha V Shah,1 Samuel K Houston,1 Arnold M Markoe,2 William Feuer,3 Timothy G Murray1,2,4

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 2Department of Radiation Oncology, University of Miami Miller School of Medicine, 3Department of Biostatistics, University of Miami, 4Murray Ocular Oncology and Retina, Miami, FL, USA

Purpose: To evaluate the benefits of intravitreal bevacizumab in patients with visually compromising radiation maculopathy following iodine-125 plaque brachytherapy for uveal melanoma.
Methods: In this Institutional Review Board-approved, consecutive, retrospective study from 2006–2009 of patients maintaining 20/50 or better vision following treatment for visually compromising radiation maculopathy, patients were evaluated with spectral domain optical coherence tomography at 2–4 month intervals following plaque removal. Treatment with intravitreal bevacizumab commenced at the first signs of radiation vasculopathy on spectral domain optical coherence tomography with associated decreased best corrected visual acuity, followed by repeat injections for recurrent or persistent vasculopathic changes.
Results: At 3 years following plaque brachytherapy, 81 of 159 (50.9%) patients treated for radiation maculopathy demonstrated 20/50 or better vision at median follow up of 36 months, which demonstrates significant improvement in vision as compared to the Collaborative Ocular Melanoma Study (P < 0.0001). These 81 patients were given a mean of five injections (range 1–17) over a mean of 17.6 months (range 1–54 months), starting at 15.8 months (range 3–50 months) after plaque brachytherapy. For those eyes that maintained 20/50 or better vision at the final follow-up, pretreatment mean best corrected visual acuity of 20/43 improved to 20/31.
Conclusion: This study demonstrates that spectral domain optical coherence tomography can detect early vasculopathic changes secondary to radiation maculopathy and that prompt treatment with intravitreal bevacizumab may delay vision loss and maintain or possibly improve visual acuity in half of eyes diagnosed with radiation maculopathy. Radiation maculopathy remains a therapeutically manageable morbidity associated with radiation therapy for posterior uveal melanoma.

Keywords: intravitreal bevacizumab, plaque brachytherapy, BCVA, radiation maculopathy, uveal melanoma

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment

Houston SK, Shah NV, Decatur C, Lonngi M, Feuer W, Markoe AM, Murray TG

Clinical Ophthalmology 2013, 7:193-198

Published Date: 22 January 2013

Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy

Aziz HA, LaSenna CE, Vigoda M, Fernandes C, Feuer W, Aziz-Sultan MA, Murray TG

Clinical Ophthalmology 2012, 6:1601-1606

Published Date: 4 October 2012

Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification

Parke III DW, Sisk RA, Murray TG

Clinical Ophthalmology 2012, 6:1347-1353

Published Date: 17 August 2012

Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification

Parke III DW, Sisk RA, Houston SK, Murray TG

Clinical Ophthalmology 2012, 6:925-931

Published Date: 18 June 2012

Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors

Piña Y, Houston SK, Murray TG, Koru-Sengul T, Decatur C, Scott WK, Nathanson L, Clarke J, Lampidis TJ

Clinical Ophthalmology 2012, 6:817-830

Published Date: 29 May 2012

Can children undergoing ophthalmologic examinations under anesthesia be safely anesthetized without using an IV line?

Vigoda M, Latiff A, Murray T, Tutiven J, Berrocal A, Gayer S

Clinical Ophthalmology 2011, 5:503-508

Published Date: 20 April 2011

Clinical imaging and high-resolution ultrasonography in melanocytoma management

Daniel Gologorsky, Amy C Schefler, Fiona J Ehlies, et al

Clinical Ophthalmology 2010, 4:855-859

Published Date: 28 July 2010

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration

R Prince Davis, Amy C Schefler, Timothy G Murray

Clinical Ophthalmology 2010, 4:703-707

Published Date: 28 June 2010

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010